According to the company, Elzofri is the first patented long-acting injectable paliperidone palmitate developed in China and approved by the FDA for the treatment of schizophrenia and schizoaffective disorder.
FDA Approves Luye Pharma Group’s Erzofri for Adult Patients with Schizophrenia and Schizoaffective Disorder
Leave a comment
